Taken together, our results suggest that IL-6 knockdown can increase chemo-drug efficacy, reduce drug resistance, inhibit tumor growth and reduce the potential for tumor recurrence and metastasis in laryngeal cancer. Here, IL6 is linked to laryngeal carcinoma.